Global Advanced Renal Cell Carcinoma Therapeutics Market 2018-2024: Opportunities, Future Trends, Growing Demand, Analysis, Forecast & Industry Developments

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 106
This report focuses on the global Advanced Renal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Advanced Renal Cell Carcinoma Therapeutics development in United States, Europe and China.

Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell carcinoma is the most common type of kidney cancer in adults that represents nearly 2-3% of all cancer cases in adults. The disorder is asymptomatic in advanced renal cell carcinoma at initial stages that results with people often in the advanced stages of the disease by the time it is discovered. The initial symptoms of renal cell carcinoma are a general feeling of being unwell, hypertension, flank pain, weight loss, fever, blood in the urine, night sweats, and a mass in the abdomen. Management of renal cell carcinoma has seen significant development in the past few years, and new approaches are being established. Advanced renal cell carcinoma is a disease that normally cannot be treated by general therapy and is challenging to treat. Surgical removal of one or both kidneys should be considered in patients who suffer from metastatic disease before systemic therapy.
Increase in aging population is one of the major factors driving the revenue growth of the renal cell carcinoma market. Furthermore, renal cell carcinoma is a rare disease with a small patient-base constitutingall ages from infants to older adults.  However, the disease is predominantly noted in age group of ~ 60-70 years, exposing a higher probability of occurrence. Expanding research into orphan drugs is a factor projected to create lucrative revenue potential for drug makers of renal cell carcinoma.
Restraints include lack of technological advances in genome sequencing, stagnant number of diagnosed population base and low patient awareness levels among others.The disease pattern of renal cell carcinoma disease is also affected by the genomic alteration, changes in lifestyle etc. Other inevitable restraints include lack of product availability on specific diseases & target indications apart from feeble pipeline.
In 2017, the global Advanced Renal Cell Carcinoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    Acceleron Pharma
    Argos Therapeutics
    AVEO Pharmaceuticals
    Bayer
    Bristol-Myers Squibb Company
    Eisai
    Exelixi
    Genentech
    Immatics Biotechnologies
    Merck
    Novartis
    Ono Pharmaceutical
    Pfizer
    Rexahn Pharmaceuticals
    Hoffmann-La Roche

Market segment by Type, the product can be split into
    Radiation Therapy
    Chemotherapy
    Hormone Therapy
    Investigational Therapy

Market segment by Application, split into
    Hospitals
    Cancer Research Institutes
    Ambulatory Surgical Centers
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Advanced Renal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Advanced Renal Cell Carcinoma Therapeutics development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Advanced Renal Cell Carcinoma Therapeutics are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (2013-2025)
        1.4.2 Radiation Therapy
        1.4.3 Chemotherapy
        1.4.4 Hormone Therapy
        1.4.5 Investigational Therapy
    1.5 Market by Application
        1.5.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2025)
        1.5.2 Hospitals
        1.5.3 Cancer Research Institutes
        1.5.4 Ambulatory Surgical Centers
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Advanced Renal Cell Carcinoma Therapeutics Market Size
    2.2 Advanced Renal Cell Carcinoma Therapeutics Growth Trends by Regions
        2.2.1 Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (2013-2025)
        2.2.2 Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Advanced Renal Cell Carcinoma Therapeutics Market Size by Manufacturers
        3.1.1 Global Advanced Renal Cell Carcinoma Therapeutics Revenue by Manufacturers (2013-2018)
        3.1.2 Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Advanced Renal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
    3.2 Advanced Renal Cell Carcinoma Therapeutics Key Players Head office and Area Served
    3.3 Key Players Advanced Renal Cell Carcinoma Therapeutics Product/Solution/Service
    3.4 Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018)
    4.2 Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018)

5 United States
    5.1 United States Advanced Renal Cell Carcinoma Therapeutics Market Size (2013-2018)
    5.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in United States
    5.3 United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
    5.4 United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Application

6 Europe
    6.1 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size (2013-2018)
    6.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Europe
    6.3 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
    6.4 Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application

7 China
    7.1 China Advanced Renal Cell Carcinoma Therapeutics Market Size (2013-2018)
    7.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in China
    7.3 China Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
    7.4 China Advanced Renal Cell Carcinoma Therapeutics Market Size by Application

8 Japan
    8.1 Japan Advanced Renal Cell Carcinoma Therapeutics Market Size (2013-2018)
    8.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Japan
    8.3 Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
    8.4 Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size (2013-2018)
    9.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Southeast Asia
    9.3 Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
    9.4 Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Application

10 India
    10.1 India Advanced Renal Cell Carcinoma Therapeutics Market Size (2013-2018)
    10.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in India
    10.3 India Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
    10.4 India Advanced Renal Cell Carcinoma Therapeutics Market Size by Application

11 Central & South America
    11.1 Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size (2013-2018)
    11.2 Advanced Renal Cell Carcinoma Therapeutics Key Players in Central & South America
    11.3 Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type
    11.4 Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application

12 International Players Profiles
    12.1 Acceleron Pharma
        12.1.1 Acceleron Pharma Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.1.4 Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.1.5 Acceleron Pharma Recent Development
    12.2 Argos Therapeutics
        12.2.1 Argos Therapeutics Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.2.4 Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.2.5 Argos Therapeutics Recent Development
    12.3 AVEO Pharmaceuticals
        12.3.1 AVEO Pharmaceuticals Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.3.4 AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.3.5 AVEO Pharmaceuticals Recent Development
    12.4 Bayer
        12.4.1 Bayer Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.4.4 Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.4.5 Bayer Recent Development
    12.5 Bristol-Myers Squibb Company
        12.5.1 Bristol-Myers Squibb Company Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.5.4 Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.5.5 Bristol-Myers Squibb Company Recent Development
    12.6 Eisai
        12.6.1 Eisai Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.6.4 Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.6.5 Eisai Recent Development
    12.7 Exelixi
        12.7.1 Exelixi Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.7.4 Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.7.5 Exelixi Recent Development
    12.8 Genentech
        12.8.1 Genentech Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.8.4 Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.8.5 Genentech Recent Development
    12.9 Immatics Biotechnologies
        12.9.1 Immatics Biotechnologies Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.9.4 Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.9.5 Immatics Biotechnologies Recent Development
    12.10 Merck
        12.10.1 Merck Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Advanced Renal Cell Carcinoma Therapeutics Introduction
        12.10.4 Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
        12.10.5 Merck Recent Development
    12.11 Novartis
    12.12 Ono Pharmaceutical
    12.13 Pfizer
    12.14 Rexahn Pharmaceuticals
    12.15 Hoffmann-La Roche

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Advanced Renal Cell Carcinoma Therapeutics Key Market Segments
    Table Key Players Advanced Renal Cell Carcinoma Therapeutics Covered
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Market Share by Type 2013-2025
    Figure Radiation Therapy Figures
    Table Key Players of Radiation Therapy
    Figure Chemotherapy Figures
    Table Key Players of Chemotherapy
    Figure Hormone Therapy Figures
    Table Key Players of Hormone Therapy
    Figure Investigational Therapy Figures
    Table Key Players of Investigational Therapy
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
    Figure Hospitals Case Studies
    Figure Cancer Research Institutes Case Studies
    Figure Ambulatory Surgical Centers Case Studies
    Figure Others Case Studies
    Figure Advanced Renal Cell Carcinoma Therapeutics Report Years Considered
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2025 (Million US$)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions 2013-2025 (Million US$)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions 2013-2018 (Million US$)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions 2013-2018
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions 2013-2018
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Regions 2018
    Table Market Top Trends
    Table Global Advanced Renal Cell Carcinoma Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Manufacturers (2013-2018)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Share by Manufacturers in 2018
    Table Global Advanced Renal Cell Carcinoma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Advanced Renal Cell Carcinoma Therapeutics Product/Solution/Service
    Table Date of Enter into Advanced Renal Cell Carcinoma Therapeutics Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Type (2013-2018)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Market Share by Type (2013-2018)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Application (2013-2018)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Market Share by Application (2013-2018)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Revenue Market Share by Application in 2017
    Figure United States Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2018 (Million US$)
    Table United States Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2017-2018) (Million US$)
    Table United States Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2017-2018)
    Table United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table United States Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2013-2018)
    Table United States Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table United States Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2018)
    Figure Europe Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2018 (Million US$)
    Table Europe Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2017-2018) (Million US$)
    Table Europe Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2017-2018)
    Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2013-2018)
    Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Europe Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2018)
    Figure China Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2018 (Million US$)
    Table China Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2017-2018) (Million US$)
    Table China Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2017-2018)
    Table China Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table China Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2013-2018)
    Table China Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table China Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2018)
    Figure Japan Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2018 (Million US$)
    Table Japan Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2017-2018) (Million US$)
    Table Japan Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2017-2018)
    Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2013-2018)
    Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Japan Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2018)
    Figure Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2017-2018)
    Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2013-2018)
    Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2018)
    Figure India Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2018 (Million US$)
    Table India Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2017-2018) (Million US$)
    Table India Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2017-2018)
    Table India Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table India Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2013-2018)
    Table India Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table India Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2018)
    Figure Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Advanced Renal Cell Carcinoma Therapeutics Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Advanced Renal Cell Carcinoma Therapeutics Market Share (2017-2018)
    Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Share by Type (2013-2018)
    Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Share by Application (2013-2018)
    Table Acceleron Pharma Company Details
    Table Acceleron Pharma Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018) (Million US$)
    Figure Acceleron Pharma Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Acceleron Pharma Recent Development
    Table Argos Therapeutics Company Details
    Table Argos Therapeutics Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Argos Therapeutics Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Argos Therapeutics Recent Development
    Table AVEO Pharmaceuticals Company Details
    Table AVEO Pharmaceuticals Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure AVEO Pharmaceuticals Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table AVEO Pharmaceuticals Recent Development
    Table Bayer Company Details
    Table Bayer Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Bayer Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Bayer Recent Development
    Table Bristol-Myers Squibb Company Company Details
    Table Bristol-Myers Squibb Company Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Bristol-Myers Squibb Company Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Bristol-Myers Squibb Company Recent Development
    Table Eisai Company Details
    Table Eisai Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Eisai Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Eisai Recent Development
    Table Exelixi Company Details
    Table Exelixi Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Exelixi Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Exelixi Recent Development
    Table Genentech Company Details
    Table Genentech Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Genentech Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Genentech Recent Development
    Table Immatics Biotechnologies Company Details
    Table Immatics Biotechnologies Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Immatics Biotechnologies Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Immatics Biotechnologies Recent Development
    Table Merck Company Details
    Table Merck Revenue in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)(Million US$)
    Figure Merck Revenue Growth Rate in Advanced Renal Cell Carcinoma Therapeutics Business (2013-2018)
    Table Merck Recent Development
    Table Novartis Company Details
    Table Ono Pharmaceutical Company Details
    Table Pfizer Company Details
    Table Rexahn Pharmaceuticals Company Details
    Table Hoffmann-La Roche Company Details
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Regions (Million US$) 2018-2025
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Regions (2018-2025)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size Share by Regions in 2025
    Figure United States Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure China Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure India Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Advanced Renal Cell Carcinoma Therapeutics Market Size Forecast (2018-2025)(Million USD)
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Product (2018-2025) (Million US$)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Product (2018-2025)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Product in 2025
    Table Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2018-2025) (Million US$)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application (2018-2025)
    Figure Global Advanced Renal Cell Carcinoma Therapeutics Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...